![SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes | tctmd.com SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes | tctmd.com](https://d18mqtxkrsjgmh.cloudfront.net/public/styles/large_slide_teaser/public/2021-11/0aca3ad7-33c1-4164-82b7-f23d3ecf39a6.png?itok=WJvr74JT)
SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes | tctmd.com
![Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention | Cardiovascular Diabetology | Full Text Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention | Cardiovascular Diabetology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12933-020-01111-7/MediaObjects/12933_2020_1111_Fig1_HTML.png)
Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention | Cardiovascular Diabetology | Full Text
![Long-term diabetes in BBDP rats is associated with enhanced in-stent... | Download Scientific Diagram Long-term diabetes in BBDP rats is associated with enhanced in-stent... | Download Scientific Diagram](https://www.researchgate.net/publication/49845696/figure/fig4/AS:203149060120600@1425445918683/Long-term-diabetes-in-BBDP-rats-is-associated-with-enhanced-in-stent-restenosis-4-weeks.png)
Long-term diabetes in BBDP rats is associated with enhanced in-stent... | Download Scientific Diagram
![Amphilimus- vs zotarolimus-eluting stents: Any preference in patients with diabetes? | Latest news for Doctors, Nurses and Pharmacists | Pharmacy Amphilimus- vs zotarolimus-eluting stents: Any preference in patients with diabetes? | Latest news for Doctors, Nurses and Pharmacists | Pharmacy](https://pubmiddleware.mims.com/resource/image/799C3344-A8D2-4D76-92A6-AF2C0115DD19/OriginalThumbnail/THUMBNAIL_shutterstock_1822505162.jpg)
Amphilimus- vs zotarolimus-eluting stents: Any preference in patients with diabetes? | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
![In patients without stent fracture, major adverse cardiac events (MACE)... | Download Scientific Diagram In patients without stent fracture, major adverse cardiac events (MACE)... | Download Scientific Diagram](https://www.researchgate.net/publication/317782794/figure/fig4/AS:961372577882153@1606220492761/In-patients-without-stent-fracture-major-adverse-cardiac-events-MACE-and-target-vessel.gif)
In patients without stent fracture, major adverse cardiac events (MACE)... | Download Scientific Diagram
![Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus - ScienceDirect Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2772930322000175-fx1.jpg)
Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus - ScienceDirect
![TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR) | tctmd.com TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR) | tctmd.com](https://d18mqtxkrsjgmh.cloudfront.net/public/styles/large_slide_teaser/public/2020-10/6a293248-b2f6-4f7f-b55d-99c636823cf6.png?itok=IvXU7gQq)
TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR) | tctmd.com
![Frontiers | Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus Frontiers | Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus](https://www.frontiersin.org/files/MyHome%20Article%20Library/586491/586491_Thumb_400.jpg)
Frontiers | Optimal Strategy for Antiplatelet Therapy After Coronary Drug-Eluting Stent Implantation in High-Risk “TWILIGHT-like” Patients With Diabetes Mellitus
![Patients With Diabetes Undergoing PCI Have Less Target Lesion Failure With Amphilimus-eluting Stents | DAIC Patients With Diabetes Undergoing PCI Have Less Target Lesion Failure With Amphilimus-eluting Stents | DAIC](https://www.dicardiology.com/sites/default/files/styles/content_feed_large_new/public/Cre8%20coronary%20stent.jpg?itok=TPhp4f3b)